Efficacy and safety of treatment simplification to atazanavir/ritonavir+lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study - Mondi, A; Fabbiani, M; Ciccarelli, N (J Antimicrob Chemother, 2015)
, et al.